Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy-Reference-Cited by-同舟云学术

Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy

Published:2023-12-05 Issue: Volume: Page:
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Mujahid Khizra¹,Rana Isra¹,Suliman Ivan Hardianto¹,Li Zhen¹,Wu Jiang²^ORCID,He Huacheng³^ORCID,Nam Jutaek¹^ORCID

Affiliation:

1. College of Pharmacy, Chonnam National University, Gwangju 61186, South Korea

2. School of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

3. Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang 325000, P. R. China

Funder

Chonnam National University

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Biochemistry (medical),Biomedical Engineering,General Chemistry,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.3c00808

Reference195 articles.

1. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

2. Harnessing the immune system to improve cancer therapy

3. Adaptive immunity maintains occult cancer in an equilibrium state

4. Cancer nanomedicine for combination cancer immunotherapy

5. Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Forum on Biomaterials for Immune and Gene Delivery;ACS Applied Bio Materials;2024-08-19

2. Clinical Applicable Carboxymethyl Chitosan with Gel-Forming and Stabilizing Properties Based on Terminal Sterilization Methods of Electron Beam Irradiation;ACS Omega;2024-04-09